Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-26-007174·SB INVESTMENT ADVISERS
Schedule 13G ownership disclosure
Vir Biotechnology Inc
Common Stock, $0.0001 par value · CUSIP: 92764N102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SB Investment Advisers (UK) Limited
Shares: 13,116,977.00 · Class: 9.4%
- SoftBank Vision Fund (AIV M1) L.P.
Shares: 13,116,977.00 · Class: 9.4%
- SVF Endurance (Cayman) Limited
Shares: 13,116,977.00 · Class: 9.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-007174
- Form type
- SCHEDULE 13G/A
- Filer
- SB INVESTMENT ADVISERS
- CIK
- CIK 1731509
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership